All COPD articles
-
NewsNew guidance on obstructive breathing disorders published by NICE
NICE guideline 202 covers investigation and management of obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s
-
Video
GOLD COPD 2021 summary tour
This Guidelines summary tour highlights the new recommendations in the GOLD 2021 report, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease
-
Independent professional body guideline
GOLD COPD 2021 strategy
A clear summary of GOLD’s 2021 strategy on COPD diagnosis, management, and prevention, including recommendations on COVID-19 and COPD
-
Hosted content
COPD: LAMA/LABA therapy—Real life case studies
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200015 V2.0 -
News
GOLD COPD report 2021 published
GOLD has published its annual report on chronic obstructive lung disease, used worldwide by healthcare experts
-
Hosted content
Why you might want to review patients with COPD receiving a LAMA
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200013 -
Hosted content
COPD: Have you done enough to implement guidelines?
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200012 -
Hosted content
Why use LAMA/LABAs as initial maintenance therapy in specific COPD patients?
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200011 -
Prescribing summary card
DuoResp® Spiromax® (budesonide/formoterol)
This promotional prescribing summary card has been developed from content provided by Teva UK Limited. Information intended for UK healthcare professionals only.
Click here for prescribing information and adverse event reporting.
DUOR-GB-00021
Date of preparation: August 2020 -
Working party guideline/algorithm
Inhaler choice guideline
This management algorithm was developed by a multidisciplinary expert panel: Usmani et al and supported by Chiesi Ltd through the provision of a grant for its production.
-
NICE guideline
NICE antibiotics for COPD exacerbations guideline
This concise summary covers what to be aware of when considering antimicrobials for an acute exacerbation of COPD to avoid unnecessary prescribing.
-
NICE guideline
NICE COPD guideline
Summary of the 2019 NICE guideline on the management of COPD. Includes management of complications, and a useful treatment algorithm.
-
Feature article
Spirometry—it’s meaningless if incorrect!
With 15 years of expertise in spirometry, Chris Loveridge answers your questions about spirometry and emphasises the need to take a clinical history.
-
Feature article
Device selection in children and adults
Jane Scullion provides some simple and practical advice on optimal inhaler device selection for adults and children.
-
Feature article
Striking a balance: device choice and therapeutic dosages
Jane Scullion looks at the increasing complexity of the multitude of MDI and DPI devices that are available and the therapeutic options they offer.
-
Test and reflect
Malnutrition in patients with COPD
This CPD activity consists of five multiple-choice questions designed to test your knowledge on malnutrition in patients with COPD.
-
Tools and resources
Inhaler standards and competency document
Source: UK Inhaler Group (www.respiratoryfutures.org.uk/media/69775/ukig-inhaler-standards-january-2017.pdf). Hosted with permission. December 2016 (planned review date December 2018)
